PerkinElmer to Hold Earnings Call on Thursday, May 4, 2017

WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, May 4, 2017, after market close, the Company will release first quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert... Read more

Seven Bridges Announces Strategic Partnership With Spatial Transcriptomics

Relationship Aims to Advance Development of Innovative Tools for Visualizing and Analyzing Gene Expression within Tissue Samples April 4, 2017 CAMBRIDGE, Mass., April 4, 2017 –Seven Bridges, the biomedical data analysis company, today announced an investment in Spatial Transcriptomics, a life sciences start-up developing innovative technology to analyze tissue samples and gene expression data in... Read more

Xylem increases its 2020 financial targets and reaffirms its strategy to reflect accelerated growth driven by acquisitions

Company also reaffirms full-year 2017 guidance RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 4, 2017– At its Investor Day in Raleigh-Durham, North Carolina, Xylem (NYSE:XYL), a leading global water technology company, today will update its 2020 financial guidance and showcase the broad portfolio of smart infrastructure technologies and solutions provided by its Sensus and Visenti businesses. Xylem acquired... Read more

Xylem to host its 2017 Investor and Analyst Day

RYE BROOK, N.Y.–(BUSINESS WIRE)–Mar. 31, 2017– Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, will host its 2017 Investor and Analyst Day on Tuesday, April 4, in Raleigh Durham, N.C. Xylem President and Chief Executive Officer Patrick Decker, along with key members of his... Read more

Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors

SOUTH SAN FRANCISCO, Calif., March 27, 2017 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of Directors. Barthelemy brings over 25 years of health care industry experience to the Fluidigm Board, having served in multiple senior executive roles in the biopharmaceutical, life science tools,... Read more